Clinical Trial

The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: The REDUCE Trial

Study acronym: REDUCE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 24, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Doctors and nurses who perform heart procedures using X-ray guidance are exposed to radiation, which can be harmful over time. This exposure increases the risk of certain health problems, including cancers, eye damage (cataracts), and DNA damage. Although protective lead clothing is used to reduce exposure, it is heavy, uncomfortable, and can cause muscle and joint problems for those who wear it daily. A new radiation protection device, called RAMPART, may help reduce radiation exposure for heart specialists and their teams. It could also allow them to wear lighter protective gear-or none at all-making their work safer and more comfortable. This study will compare the radiation levels received by doctors and nurses during heart procedures when using RAMPART versus standard protection. By doing so, we hope to find out if this new device can better protect medical teams from radiation, improving both their safety and well-being.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-12.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT06875583
Lead Sponsor Liverpool Heart and Chest Hospital NHS Foundation Trust
Collaborators: Rampart Health, L.L.C.
Conditions Radiation Exposure, Radiation Exposure to Operator, Radiation Injuries, Radiation Safety
Enrollment 100 participants
Start Date 2025-08-29
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-24